64Cu-DOTA-ECL1i

64Cu-DOTA-ECL1i · Washington University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-DOTA-ECL1i, covering 2024-02-28 to 2024-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer [Phase 1]